Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Av. Bandeirantes, 3900, 14049-900, Ribeirao Preto, SP, Brazil.
Naunyn Schmiedebergs Arch Pharmacol. 2012 May;385(5):509-17. doi: 10.1007/s00210-011-0712-0. Epub 2012 Jan 20.
Dietary nitrite and nitrate have been reported as alternative sources of nitric oxide (NO). In this regard, we reported previously that sodium nitrite added to drinking water was able to exert antihypertensive effects in an experimental model of hypertension in a dose-dependent manner. Taking into consideration that nitrite is continuously converted to nitrate in the bloodstream, here we expanded our previous report and evaluate whether a single daily dose of sodium nitrite could exert antihypertensive effects in 2 kidney-1 clip (2K1C) hypertensive rats. Sham-operated and 2K1C rats were treated with vehicle or sodium nitrite (15 mg/kg/day) for 4 weeks. We evaluated the effects induced by sodium nitrite treatment on systolic blood pressure (SBP) and NO markers such as plasma nitrite, nitrite + nitrate (NOx), cGMP, and blood levels of nitrosyl-hemoglobin. In addition, we also evaluated effects of nitrite on oxidative stress and antioxidant enzymes. Dihydroethidium (DHE) was used to evaluate aortic reactive oxygen species (ROS) production by fluorescence microscopy, and plasma levels of thiobarbituric acid-reactive species (TBARS) were measured in plasma samples from all experimental groups. Red blood cell superoxide dismutase (SOD) and catalase activity were evaluated with commercial kits. Sodium nitrite treatment reduced SBP in 2K1C rats (P < 0.05). We found lower plasma nitrite and NOx levels in 2K1C rats compared with normotensive controls (both P < 0.05). Nitrite treatment restored the lower levels of nitrite and NOx. While no change was found in the blood levels of nitrosyl-hemoglobin (P > 0.05), nitrite treatment increased the plasma levels of cGMP in 2K1C rats (P < 0.05). Higher plasma TBARS levels and aortic ROS levels were found in hypertensive rats compared with controls (P < 0.05), and nitrite blunted these alterations. Lower SOD and catalase activities were found in 2K1C hypertensive rats compared with controls (both P < 0.05). Nitrite treatment restored SOD activity (P < 0.05), whereas catalase was not affected. These data suggest that even a single daily oral dose of sodium nitrite is able to lower SBP and exert antioxidant effects in renovascular hypertension.
饮食中的亚硝酸盐和硝酸盐已被报道为一氧化氮 (NO) 的替代来源。在这方面,我们之前曾报道过,添加到饮用水中的亚硝酸钠能够以剂量依赖的方式在高血压实验模型中发挥降压作用。考虑到亚硝酸盐在血液中会不断转化为硝酸盐,我们在这里扩展了之前的报告,并评估单次给予亚硝酸钠是否能在 2 肾-1 夹(2K1C)高血压大鼠中发挥降压作用。假手术和 2K1C 大鼠分别用载体或亚硝酸钠(15mg/kg/天)处理 4 周。我们评估了亚硝酸钠处理对收缩压(SBP)和 NO 标志物的影响,如血浆亚硝酸盐、硝酸盐+亚硝酸盐(NOx)、环磷酸鸟苷(cGMP)和血液中硝基血红蛋白水平。此外,我们还评估了亚硝酸盐对氧化应激和抗氧化酶的影响。二氢乙锭(DHE)用于通过荧光显微镜评估主动脉活性氧(ROS)的产生,并用所有实验组的血浆样本测量血浆中硫代巴比妥酸反应性物质(TBARS)的水平。红细胞超氧化物歧化酶(SOD)和过氧化氢酶活性用商业试剂盒进行评估。亚硝酸钠治疗降低了 2K1C 大鼠的 SBP(P<0.05)。我们发现与正常血压对照组相比,2K1C 大鼠的血浆亚硝酸盐和 NOx 水平较低(均 P<0.05)。亚硝酸钠治疗恢复了较低的亚硝酸盐和 NOx 水平。虽然血液中硝基血红蛋白的水平没有变化(P>0.05),但亚硝酸钠治疗增加了 2K1C 大鼠的血浆 cGMP 水平(P<0.05)。与对照组相比,高血压大鼠的血浆 TBARS 水平和主动脉 ROS 水平升高(P<0.05),而亚硝酸钠减轻了这些改变。与对照组相比,2K1C 高血压大鼠的 SOD 和过氧化氢酶活性降低(均 P<0.05)。亚硝酸钠治疗恢复了 SOD 活性(P<0.05),而过氧化氢酶没有受到影响。这些数据表明,即使是单次口服给予亚硝酸钠也能够降低 SBP 并在肾血管性高血压中发挥抗氧化作用。